These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8231377)

  • 21. The impact of succimer chelation on blood cadmium in children with background exposures: a randomized trial.
    Cao Y; Chen A; Bottai M; Caldwell KL; Rogan WJ
    J Pediatr; 2013 Aug; 163(2):598-600. PubMed ID: 23601497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disappearance of heme metabolites following chelation therapy with meso 2,3-dimercaptosuccinic acid (DMSA).
    Tutunji MF; al-Mahasneh QM
    J Toxicol Clin Toxicol; 1994; 32(3):267-76. PubMed ID: 8007034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The need for vigilance: the persistence of lead poisoning in children.
    Florin TA; Brent RL; Weitzman M
    Pediatrics; 2005 Jun; 115(6):1767-8. PubMed ID: 15930242
    [No Abstract]   [Full Text] [Related]  

  • 24. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.
    Miller AL
    Altern Med Rev; 1998 Jun; 3(3):199-207. PubMed ID: 9630737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
    Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
    Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unanswered questions in metal chelation.
    Kosnett MJ
    J Toxicol Clin Toxicol; 1992; 30(4):529-47. PubMed ID: 1331492
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lead intoxication and amyotrophic lateral sclerosis].
    Couratier P; Bernet-Bernady P; Truong T; Lagrange E; Preux PM; Lachatre G; Vallat JM
    Rev Neurol (Paris); 1998 May; 154(4):345-7. PubMed ID: 9773065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of lipoic acid in combination with dimercaptosuccinic acid against lead-induced renal tubular defects and on isolated brush-border enzyme activities.
    Sivaprasad TR; Malarkodi SP; Varalakshmi P
    Chem Biol Interact; 2004 Apr; 147(3):259-71. PubMed ID: 15135082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of children with elevated blood lead levels.
    Kim D; Buchanan S; Noonan G; McGeehin M
    Am J Prev Med; 2002 Jan; 22(1):71. PubMed ID: 11777685
    [No Abstract]   [Full Text] [Related]  

  • 30. Lead poisoning prevention, not chelation (commentary).
    Henretig F
    J Toxicol Clin Toxicol; 2001; 39(7):659-60. PubMed ID: 11778662
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of zinc supplementation during chelation therapy in plumbism: a case report.
    Finelli VN; Lerner S; Hong C; Lohiya G
    Med Lav; 1980; 71(2):149-56. PubMed ID: 6780775
    [No Abstract]   [Full Text] [Related]  

  • 32. Chelation therapy for childhood lead poisoning. The changing scene in the 1990s.
    Mortensen ME; Walson PD
    Clin Pediatr (Phila); 1993 May; 32(5):284-91. PubMed ID: 8391959
    [No Abstract]   [Full Text] [Related]  

  • 33. Adult chronic lead intoxication. A clinical review.
    Balestra DJ
    Arch Intern Med; 1991 Sep; 151(9):1718-20. PubMed ID: 1888236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Succimer: the first approved oral lead chelator.
    Jorgensen FM
    Am Fam Physician; 1993 Dec; 48(8):1496-502. PubMed ID: 8249780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lead poisoning in a radiator repairer.
    Lohiya GS; Lohiya S
    West J Med; 1995 Feb; 162(2):160-4. PubMed ID: 7725696
    [No Abstract]   [Full Text] [Related]  

  • 36. 2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
    Graziano JH; Siris ES; LoIacono N; Silverberg SJ; Turgeon L
    Clin Pharmacol Ther; 1985 Apr; 37(4):431-8. PubMed ID: 2983924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemolytic anemia following succimer administration in a glucose-6-phosphate dehydrogenase deficient patient.
    Gerr F; Frumkin H; Hodgins P
    J Toxicol Clin Toxicol; 1994; 32(5):569-75. PubMed ID: 7932916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The scientific basis for chelation: animal studies and lead chelation.
    Smith D; Strupp BJ
    J Med Toxicol; 2013 Dec; 9(4):326-38. PubMed ID: 24113857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Succimer in symptomatic lead poisoning.
    Kalra V; Dua T; Kumar V; Kaul B
    Indian Pediatr; 2002 Jun; 39(6):580-5. PubMed ID: 12084955
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lead poisoning treated with 2,3-dimercaptosuccinic acid].
    Devars du Mayne JF; Prevost C; Gaudin B; Languille M; Cerf M; Nordmann Y
    Presse Med; 1984 Oct; 13(36):2209. PubMed ID: 6095245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.